UCB Stock Forecast, Price & News

UCB (OTCMKTS:UCBJY) Frequently Asked Questions

Is UCB a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UCB in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UCB stock.
View analyst ratings for UCB or view top-rated stocks.

What stocks does MarketBeat like better than UCB?

Wall Street analysts have given UCB a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but UCB wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting UCB?

UCB saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 6,500 shares, an increase of 103.1% from the August 15th total of 3,200 shares. Based on an average daily volume of 17,800 shares, the short-interest ratio is currently 0.4 days.
View UCB's Short Interest.

How has UCB's stock price been impacted by COVID-19?

UCB's stock was trading at $50.3225 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, UCBJY stock has increased by 11.7% and is now trading at $56.19.
View which stocks have been most impacted by COVID-19.

How often does UCB pay dividends? What is the dividend yield for UCB?

UCB declared a dividend on Friday, April 30th. Investors of record on Monday, May 10th will be given a dividend of $1.4382 per share on Wednesday, May 19th. This represents a dividend yield of 3.08%. The ex-dividend date is Friday, May 7th.
View UCB's dividend history.

What price target have analysts set for UCBJY?

8 brokerages have issued 12-month price targets for UCB's shares. Their forecasts range from $52.84 to $52.84. On average, they anticipate UCB's share price to reach $52.84 in the next year. This suggests that the stock has a possible downside of 6.0%.
View analysts' price targets for UCB or view top-rated stocks among Wall Street analysts.

Who are UCB's key executives?

UCB's management team includes the following people:

• Jean-Christophe Tellier, Chief Executive Officer & Executive Director
• Sandrine Dufour, Chief Financial Officer & Executive Vice President
• Iris Löw-Friedrich, Chief Medical Officer & EVP-Development
• Dhavalkumar Patel, Chief Scientific Officer & Executive VP
• Herman de Prins, Chief Information Officer

Who are some of UCB's key competitors?

Some companies that are related to UCB include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR) and Annovis Bio (ANVS).
View all of UCBJY's competitors.

What is UCB's stock symbol?

UCB trades on the OTCMKTS under the ticker symbol "UCBJY."

How do I buy shares of UCB?

Shares of UCBJY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UCB's stock price today?

One share of UCBJY stock can currently be purchased for approximately $56.19.

How many employees does UCB have?

UCB employs 7,820 workers across the globe.

What is UCB's official website?

The official website for UCB is www.ucb.com.

Where are UCB's headquarters?

UCB is headquartered at Allee de la Recherche, 60, Anderlecht, Bruxelles Capitale 1070.

How can I contact UCB?

UCB's mailing address is Allee de la Recherche, 60, Anderlecht, Bruxelles Capitale 1070. The company can be reached via phone at (322) 559-9999.